Nicholas P Giustini

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Replacement Therapy

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nicholas P Giustini, Colin C Pritchard, Nikhil V Kamat, Manoj P Menon
EGFR V834L and L858R Comutation Is Associated With Response to Osimertinib in Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Nicholas P Giustini, Colin C Pritchard, Nikhil V Kamat, Manoj P Menon
EGFR V834L and L858R Comutation Is Associated With Response to Osimertinib in Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Nicholas P Giustini, Sandip Pravin Patel, Nathaniel J Myall, José Fernando do Prado Moura, Amit A Kulkarni, Richard C Chao, Heather A Wakelee, Lyudmila Bazhenova
Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF : Case Series and Literature Review of Treatment. JCO precision oncology 6 (2022)